Balda Aktiengesellschaft

EANS-News: Balda Group now with the two operating segments Balda Medical and Balda Technical (with document)

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------

Company Information/Operating segments

Bad Oeynhausen (euro adhoc) - Acquired US companies C. Brewer and HK Plastics
Engineering will be integrated into the Group structure - Half-yearly report for
2012/2013 will be published on 20 February 2013

Bad Oeynhausen, 29 January 2013 - Following the integration of C. Brewer Co. and
HK Plastics Engineering, Inc., the two US plastics specialists acquired at the
end of 2012, the Balda Group will be doing business with the two operating
segments - Balda Medical and Balda Technical.

The existing Medical segment will be expanded to include the respective
healthcare activities of the two acquired companies. It will comprise around 450
employees, who will be based in Bad Oeynhausen and at four plants in California,
USA. The segment will be headed by Dr. Rolf Eilers.

The previous Electronics Products operating segment will be renamed Balda
Technical. In addition to the site at Ipoh, Malaysia, it will also comprise
three other sites of C. Brewer and HK Plastics Engineering in California, USA.
With a workforce of more than 1,100 employees, this segment will develop,
produce and market precision plastic injection molding solutions for high-
quality optics, electronics and automotive applications. The segment will be
headed by Dominik Müser, the sole member of Balda AG's Management Board.

Balda Central Services will remain the Group's third segment. It mainly covers
the activities of Balda AG as the Group's strategic and financial holding
company and as such is not an operating segment.

The Balda Group's new segment structure, which will be introduced with the
upcoming report on the first six months (1 July to 31 December 2012) of the
current 2012/2013 financial year, is as follows:

Balda Medical and Balda Technical are independent and equal segments of the
Balda Group, Bad Oeynhausen.

Balda Medical comprises the strategic business areas Pharma, Diagnostics and
Medical Technology. Around 450 employees work in Bad Oeynhausen in Germany and
at the US sites in Anaheim, Ontario, Irvine and Oceanside. The Balda Medical
segment is run by Dr. Rolf Eilers.

Balda Technical employs around 1,100 people at its production sites in Ipoh
(Malaysia) and Anaheim and Irvine (both USA). Balda Technical comprises the
strategic business areas Optics, Electronics and Automotive. Balda Technical is
managed by Dominik Müser (CEO).

In his capacity as Chief Executive Officer, Dominik Müser also manages Balda
Central Services, whose staff of eight in Bad Oeynhausen and Amsterdam (The
Netherlands) cover the strategic services of corporate communications, capital
markets as well as financing and tax.

Due to the required integration of the two US acquisitions into the consolidated
financial statements of Balda AG, which, among other things, will involve a
changeover of the accounting to International Financial Reporting Standards
(IFRS), the 2012/2013 half-yearly report will be published on 20 February 2013
and not on 7 February 2013, as previously announced.


About Balda
Balda is an international producer of high-quality plastics products and system
solutions. The company provides superior engineering services, products of the
highest quality as well as a fast, flexible and tailored service for its
customers.
Based in Bad Oeynhausen and operating further production facilities in
California, the Balda Medical segment develops and produces high-quality
plastics solutions for the medical technology, pharmaceutical and diagnostics
markets. The Balda Technical segment comprises products and solutions for the
electronics, optics and automotive industries. It operates production facilities
in Malaysia and California.
The Balda Group generated revenues of EUR 24.7 million in the short financial
year 2012 (1 January to 30 June 2012) compared to EUR 66.3 million in calendar
year 2011. The Balda share (ISIN: DE0005215107) is listed on the SDAX segment of
Deutsche Börse.

www.balda.de
www.balda-medical.de

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/oRSA5aqX
http://resources.euroadhoc.com/us/5wWlCcyy

Further inquiry note:
Frank Elsner
Frank Elsner Kommunikation für Unternehmen GmbH
Tel.: +49 - 54 04 - 91 92 0
Fax: +49 - 54 04 - 91 92 29
Mail: office@elsner-kommunikation.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/oRSA5aqX
http://resources.euroadhoc.com/us/5wWlCcyy


company:     Balda Aktiengesellschaft
             Bergkirchener Str.  228 
             D-32549 Bad Oeynhausen
phone:       +49 (0) 5734 9 22-0
FAX:         +49 (0) 5734  922-2604
mail:     info@balda.de
WWW:      http://www.balda.de
sector:      Semiconductors & active components
ISIN:        DE0005215107
indexes:     SDAX, Prime All Share
stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart,
             regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: Balda Aktiengesellschaft

Das könnte Sie auch interessieren: